oxazoles has been researched along with Colorectal Cancer in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, D; Bekaii-Saab, T; Walden, D | 1 |
| Dash, P; Ehrnström, R; Fred Mehrabi, S; Lydrup, ML; Olsson, R; Satapathy, SR; Sjölander, A; Topi, G | 1 |
| Anbardar, MH; Mohammadi, S; Salmanpour, M; Samani, SM; Tamaddon, A; Yousefi, G | 1 |
| Alexander, C; Ashford, MB; Barnes, J; Barry, ST; England, RM; Hare, JI; Kemmitt, PD; Smith, A; Strittmatter, N; Waring, MJ; Wilson, J | 1 |
| Bétous, R; Biard, DS; Cazaux, C; Hoffmann, JS; Pillaire, MJ; Puget, N; Rey, L; Selves, J; Shin-ya, K; Vasquez, KM; Wang, G | 1 |
| DuBois, RN; Guo, L; Ning, W; Wang, D; Xie, D | 1 |
| Enomoto, M; Gonda, T; Higuchi, T; Kobayashi, H; Sugihara, K; Uetake, H | 1 |
| Enomoto, M; Higuchi, T; Kobayashi, H; Sugihara, K; Uetake, H | 1 |
| Bouancheau, D; Denis, MG; Jarry, A; Laboisse, CL; Masson, D; Mosnier, JF; Mottier, S; Toquet, C | 1 |
| Masaki, M; Sasai, H; Wakitani, K | 1 |
10 other study(ies) available for oxazoles and Colorectal Cancer
| Article | Year |
|---|---|
Tucatinib: an investigational novel therapeutic agent for the treatment of HER-2 colorectal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Drugs, Investigational; Female; Humans; Lung Neoplasms; Oxazoles; Protein Kinase Inhibitors; Pyridines; Quinazolines; Receptor, ErbB-2; Trastuzumab | 2022 |
Tumour-suppressive effect of oestrogen receptor β in colorectal cancer patients, colon cancer cells, and a zebrafish model.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caco-2 Cells; Cell Movement; Cell Proliferation; Colorectal Neoplasms; Estrogen Receptor beta; Female; Genes, APC; HCT116 Cells; HT29 Cells; Humans; Mice, Inbred C57BL; Mice, Transgenic; Neoplasm Metastasis; Oxazoles; Receptors, Leukotriene; Signal Transduction; Xenograft Model Antitumor Assays; Zebrafish | 2020 |
Nanoparticulate delivery of irinotecan active metabolite (SN38) in murine colorectal carcinoma through conjugation to poly (2-ethyl 2-oxazoline)-b-poly (L-glutamic acid) double hydrophilic copolymer.
Topics: Animals; Cell Line, Tumor; Colorectal Neoplasms; Drug Delivery Systems; Female; Glutamic Acid; Hydrophobic and Hydrophilic Interactions; Irinotecan; Mice; Mice, Inbred BALB C; Nanoparticles; Oxazoles; Polymers | 2019 |
Tumour regression and improved gastrointestinal tolerability from controlled release of SN-38 from novel polyoxazoline-modified dendrimers.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Colon; Colorectal Neoplasms; Delayed-Action Preparations; Dendrimers; Female; Irinotecan; Mice; Mice, Nude; Oxazoles; Rats, Wistar; Rectum | 2017 |
Role of TLS DNA polymerases eta and kappa in processing naturally occurring structured DNA in human cells.
Topics: Adenocarcinoma; Blotting, Western; Bone Neoplasms; Colony-Forming Units Assay; Colorectal Neoplasms; DNA Damage; DNA Polymerase iota; DNA Replication; DNA-Directed DNA Polymerase; Flow Cytometry; G-Quadruplexes; Gene Silencing; Genes, myc; HeLa Cells; Histones; Humans; Nucleic Acid Synthesis Inhibitors; Osteosarcoma; Oxazoles; Promoter Regions, Genetic | 2009 |
Peroxisome proliferator-activated receptor δ confers resistance to peroxisome proliferator-activated receptor γ-induced apoptosis in colorectal cancer cells.
Topics: Apoptosis; Caspase 3; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; DNA Fragmentation; Gene Expression; Gene Expression Regulation, Neoplastic; Gene Knockout Techniques; Humans; Inhibitor of Apoptosis Proteins; Oxazoles; PPAR delta; PPAR gamma; Survivin; Thiazoles; Tyrosine | 2012 |
JTE-522, a selective COX-2 inhibitor, interferes with the growth of lung metastases from colorectal cancer in rats due to inhibition of neovascularization: a vascular cast model study.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Benzenesulfonates; Cell Line, Tumor; Colorectal Neoplasms; Cyclooxygenase 2; Enzyme Inhibitors; Isoenzymes; Logistic Models; Lung Neoplasms; Male; Microcirculation; Microscopy, Electron, Scanning; Neovascularization, Pathologic; Oxazoles; Prostaglandin-Endoperoxide Synthases; Pulmonary Circulation; Rats; Rats, Inbred F344 | 2004 |
JTE-522, a selective COX-2 inhibitor, inhibits growth of pulmonary metastases of colorectal cancer in rats.
Topics: Animals; Benzenesulfonates; Colorectal Neoplasms; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Lung; Lung Neoplasms; Organ Size; Oxazoles; Rats; Rats, Inbred F344; Vascular Endothelial Growth Factor A | 2005 |
Low expression of ORF4, a dominant negative variant of peroxisome proliferator-activated receptor gamma, in colorectal adenocarcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Alternative Splicing; Caco-2 Cells; Cell Line, Tumor; Colorectal Neoplasms; Female; Gene Expression Regulation, Neoplastic; HT29 Cells; Humans; Male; Middle Aged; Oxazoles; PPAR gamma; Protein Isoforms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tyrosine | 2007 |
Suppression of polypogenesis in a new mouse strain with a truncated Apc(Delta474) by a novel COX-2 inhibitor, JTE-522.
Topics: Adenomatous Polyposis Coli; Amino Acid Sequence; Animals; Base Sequence; Benzenesulfonates; Colorectal Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Female; Genes, APC; Genotype; Isoenzymes; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Molecular Sequence Data; Mutation; Oxazoles; Prostaglandin-Endoperoxide Synthases; Reverse Transcriptase Polymerase Chain Reaction | 2000 |